Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)

NCT02919735 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia

Interventions

DRUG: CG 428 cutaneous solution
DRUG: Placebo cutaneous solution

Sponsor

Legacy Healthcare SA